Option chain shows key data for Eagle Pharmaceuticals's stock options at various strike prices and expiration dates. Traders use this information to analyze potential trades and assess market sentiment for Eagle Pharmaceuticals.

Eagle Pharmaceuticals (OTC:EGRX) Stock, Option Chain

Eagle Pharmaceuticals

Eagle Pharmaceuticals Inc is a specialty pharmaceutical company. The company develops and commercializes injectable products in the areas of critical care, orphan diseases, and oncology. Its product portfolio consists of four approved products: Argatroban, Ryanodex, Belrapzo, and Bendeka. The company currently has multiple product candidates in advanced stages of development and is under review for approval by the Food and Drug Administration.

oil rig

Earnings

Equities

News

Eurozone

Commodities

Markets

Trading Ideas

ADTX

EGRX

JOBY

Crude Oil Edges Higher; ConAgra Posts Downbeat Earnings

Apple, Nio, CVS Health, Stellantis, Tesla: Why These 5 Stocks Are On Investors' Radars Today

Intraday Update

GLDD

Dow Gains 100 Points; Joby Aviation Shares Spike Higher

Wall Street

AREB

KXIN

US Stocks Edge Lower; Private Employment Beats Expectations

EAGLE PHARMS INC by Eagle Pharmaceuticals, Inc.

Eagle Pharmaceuticals Inc

Press Releases

Eagle Pharmaceuticals Announces Receipt of Delisting Notification from Nasdaq

Legal

Investigation Alert: Aldeyra, Eagle Pharmaceuticals, and Blue Ridge Bankshares: Johnson Fistel, LLP Encourages Long-Term Investors to Submit Their Information Below

Aldeyra, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

Snowflake, Eagle Pharmaceuticals, Blue Ridge Bankshares, and Amplitude Investigation Alert: Johnson Fistel, LLP Encourages Long-Term Investors to Reach Out for More Information

Eagle Pharmaceuticals Adopts Limited Duration Stockholder Rights Plan

Management

Eagle Pharmaceuticals Appoints Christopher Krawtschuk as Chief Financial Officer

Eagle Announces Update on Delisting from Nasdaq and SEC Deregistration

Eagle Pharmaceuticals Announces Amendment to Limited Duration Stockholder Rights Plan

Financing

Contracts

Eagle Pharmaceuticals Announces $69 Million Agreement to Monetize BENDEKA® Royalties

Comments

Eagle Pharmaceuticals

Eagle Pharmaceuticals (EGRX) Options

No option chain data available. Please try again later

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell